Peng Lu

Title: The Innovations of Peng Lu

Introduction

Peng Lu is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for capsid protein assembly. With a total of 3 patents, his work is focused on addressing diseases caused by hepatitis B virus infection.

Latest Patents

Peng Lu's latest patents include innovative compounds that serve as capsid protein assembly inhibitors. One of his notable inventions is a pharmaceutical composition that includes a compound of formula I or II, which can be a stereoisomer, a tautomer, a geometrical isomer, a solvate, an active metabolite, a hydrate, a prodrug, or a pharmaceutically acceptable salt. This composition is designed for medical use in treating diseases that benefit from the capsid protein assembly inhibitor, particularly those caused by hepatitis B virus infection. Another patent focuses on a similar N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, emphasizing its pharmaceutical composition and medical applications.

Career Highlights

Peng Lu is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His work at this esteemed company has allowed him to advance his research and contribute to the development of effective treatments for viral infections.

Collaborations

Throughout his career, Peng Lu has collaborated with notable colleagues, including Yinsheng Zhang and Wangwei Ao. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical field.

Conclusion

Peng Lu's contributions to the pharmaceutical industry, particularly in the development of capsid protein assembly inhibitors, highlight his role as a significant inventor. His work continues to pave the way for advancements in treating hepatitis B virus infections.